ALBANY, N.Y., Feb. 21, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo, President and Chief Executive Officer, will present at the following investor conferences in late February.

• The Citi Global Health Care Conference at the Waldorf Astoria Hotel in New York City. Mr. DeVivo is scheduled to provide an overview of the Company on Monday, February 27, 2012, at 10:00 a.m. ET.
   
• The RBC Global Healthcare Conference at the New York Palace in New York City. Mr. DeVivo is scheduled to present on Tuesday, February 28, 2012, at 4:05 p.m. ET.

A live webcast and subsequent archived replay of AngioDynamics' presentations at these conferences may be accessed via the investor relations section of the Company's Web site under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.

CONTACT: Company Contact:

         AngioDynamics, Inc.D. Joseph Gersuk, CFO

         (800) 772-6446 x1608

         jgersuk@AngioDynamics.com



         Investor Relations Contacts:

         EVC Group, Inc.Doug Sherk/ Greg Gin

         (415) 568-4887; (646) 445-4801

         dsherk@evcgroup.com; ggin@evcgroup.com



         Media Contact:

         EVC Group, Inc.Steve DiMattia

         (646) 201-5445

         sdimattia@evcgroup.com

News Provided by Acquire Media